<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-A49ZDN60</identifier><date>2012</date><creator>Tavčar, Petra</creator><relation>documents/doc/A/URN_NBN_SI_doc-A49ZDN60_001.pdf</relation><relation>documents/doc/A/URN_NBN_SI_doc-A49ZDN60_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 78-82</format><identifier identifier_type="COBISSID_HOST">1298043</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-A49ZDN60</identifier><language>slv</language><publisher>Kancerološko združenje Slovenskega zdravniškega društva</publisher><publisher>Onkološki inštitut</publisher><source>Onkološki vikend</source><rights>BY-NC-ND</rights><subject language_type_id="eng">Cachexia</subject><subject language_type_id="eng">Drug therapy</subject><subject language_type_id="eng">Enteral nutrition</subject><subject language_type_id="slv">farmakologija</subject><subject language_type_id="slv">kaheksija</subject><subject language_type_id="eng">Neoplasms</subject><subject language_type_id="slv">onkologija</subject><title>Farmakološka obravnava kaheksije pri bolnikih z rakom</title><title>pregled interakcij</title></Record>